Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, Poole CJ, Maraveyas A, Levine M. Young AM, et al. Among authors: hobbs fdr. J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746227 Clinical Trial.
Thromboembolism.
Fitzmaurice DA, Hobbs FD, McManus RJ. Fitzmaurice DA, et al. Am Fam Physician. 2002 Aug 1;66(3):475-7. Am Fam Physician. 2002. PMID: 12182526 Free article. Review. No abstract available.
Thromboembolism.
Fitzmaurice DA, Hobbs FD, McManus RJ. Fitzmaurice DA, et al. Am Fam Physician. 2004 Jan 1;69(1):132-4. Am Fam Physician. 2004. PMID: 14727830 Free article. Review. No abstract available.
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
Cools F, Virdone S, Sawhney J, Lopes RD, Jacobson B, Arcelus JI, Hobbs FDR, Gibbs H, Himmelreich JCL, MacCallum P, Schellong S, Haas S, Turpie AGG, Ageno W, Rocha AT, Kayani G, Pieper K, Kakkar AK; ETHIC investigators. Cools F, et al. Among authors: hobbs fdr. Lancet Haematol. 2022 Aug;9(8):e594-e604. doi: 10.1016/S2352-3026(22)00173-9. Epub 2022 Jun 30. Lancet Haematol. 2022. PMID: 35779560 Free PMC article. Clinical Trial.
[Thromboembolism].
Fitzmaurice DA, Hobbs FD. Fitzmaurice DA, et al. Vasa. 2001 May;30(2):141-5. doi: 10.1024/0301-1526.30.2.141. Vasa. 2001. PMID: 11417288 German. No abstract available.
Thromboembolism.
Fitzmaurice D, Hobbs FD, McManus R. Fitzmaurice D, et al. Clin Evid. 2002 Jun;(7):199-213. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):209-24.. PMID: 12230644 Updated. Review. No abstract available.
Thromboembolism.
Fitzmaurice D, Hobbs FD, McManus R. Fitzmaurice D, et al. Clin Evid. 2002 Dec;(8):209-24. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):273-88.. PMID: 12603878 Updated. Review. No abstract available.
Thromboembolism.
Fitzmaurice D, Hobbs FD, McManus R. Fitzmaurice D, et al. Clin Evid. 2004 Dec;(12):285-308. Clin Evid. 2004. Update in: Clin Evid. 2005 Dec;(14):198-215.. PMID: 15865639 Updated. Review. No abstract available.
347 results